LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Aandelen Lijst・DaVita Inc

DaVita Inc

Gesloten

SectorGezondheidszorg

192.17 -1.28

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

190.9

Max

198.59

Belangrijke statistieken
By Trading Economics
Inkomsten	-804M 275M
Verkoop	-204M 3.4B
K/W Sectorgemiddelde	18.286 49.888
EPS	2.87
Winstmarge	8.052
Werknemers	78,000
EBITDA	-62M 655M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+8.19% upside

Dividenden
By Dow Jones
Volgende Winsten	4 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	2B 12B
Vorige openingsprijs	193.45
Vorige sluitingsprijs	192.17

Nieuwssentiment

By Acuity

68%

32%

298 / 344 Rangschikking in Healthcare

DaVita Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 dec 2025, 06:30 UTC

Acquisities, Fusies, Overnames

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

Peer Vergelijking

Prijswijziging

DaVita Inc Prognose

Koersdoel

By TipRanks

8.19% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 211 USD 8.19%

Hoogste 235 USD

Laagste 194 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor DaVita Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan DaVita Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

298 / 344 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.